Clinical trial
Efficacy and Safety of MBP8298 in Subjects With Secondary Progressive Multiple…
NCT00468611 · BioMS Technology Corp., Industry · Terminated
Key facts
| NCT number | NCT00468611 |
|---|---|
| Title | Efficacy and Safety of MBP8298 in Subjects With Secondary Progressive Multiple Sclerosis |
| Official title | A Double-Blind, Placebo Controlled Multi-Center Study to Evaluate the Efficacy and Safety of MBP8298 in Subjects With Secondary Progressive Multiple Sclerosis |
| Acronym | MAESTRO-03 |
| Lead sponsor | BioMS Technology Corp., Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Multiple Sclerosis, Secondary Progressive |
| Intervention type | Drug |
| Interventions | MBP8298 |
| Enrollment | 510 |
| Start date | Jun 1, 2007 |
| Primary completion | Jul 1, 2009 |
| Completion | Sep 1, 2009 |
| First posted | May 3, 2007 |
| Last update posted | Aug 13, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: